MedPage Today on MSN
Year in Review: Alzheimer's Disease
News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers ...
New research published in the journal Nature suggests that modest doses of lithium orotate may prevent or even reverse ...
Scientists have uncovered a surprising mechanism by which a brain enzyme called OTULIN controls the expression of tau, the ...
Rutgers neuroscientist Peng Jiang and his neuroscience colleague Mengmeng Jin have made a discovery they say could reshape ...
The actor’s National Geographic documentary shows the power of memory and social connection in supporting his father’s ...
The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a ...
13hon MSN
Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says
An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...
Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...
MedPage Today on MSN
Highly Anticipated Alzheimer's Trials Yield Disappointing Results for GLP-1 Drug
The biomarker improvements in the EVOKE studies are worth noting, observed Howard Fillit, MD, of the Alzheimer's Drug ...
Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral ...
FOX 32 Chicago on MSN
How to spot signs of Alzheimer's disease in a loved one
Choose a calm moment, listen first and give the person time to share how they feel. Here are some other tips on how to help a ...
An older oral version of the company's semaglutide drug failed to meet its main goal in late-stage trials testing whether the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results